PKI News and Press, PerkinElmer Inc. From 08/19/20

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Baird's 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 8:30 a.m. ET. Jamey Mock, senior vice president and chief f...

Investment Thesis We are bullish on Bio-Rad Laboratories (BIO) in light of recent performance coming out of Q2 2020. Shareholders have enjoyed 37.77% in price returns YTD with 5.36% risk to the downside, whilst long-time shareholders have garnered ~250% gain in returns over the past 5 years,...

Instrument also tests ethanol and isopropanol concentrations to confirm product efficacy PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of...

Enables Labs to Quickly Ramp up Testing Capacity and Generate Results Faster PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of prepa...

PerkinElmer, Inc. (PKI) Q2 2020 Earnings Conference Call July 28, 2020 5:00 PM ET Company Participants Bryan Kipp – Vice President-Investor Relations Prahlad Singh – President and Chief Executive Officer Jamey Mock – Senior Vice President and Chief Financial ...

PerkinElmer (NYSE: PKI ) Q2 results : More news on: PerkinElmer, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...

PerkinElmer (NYSE: PKI ) : Q2 Non-GAAP EPS of $1.57 beats by $0.69 ; GAAP EPS of $1.23 beats by $0.52 . More news on: PerkinElmer, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

Revenue of $811.7 million; 12% reported growth; 13% organic growth GAAP EPS from continuing operations of $1.23; Adjusted EPS of $1.57 PerkinElmer, Inc . (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the seco...

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...

PerkinElmer (NYSE: PKI ) launches dry blood spot-based test for SARS-CoV-2 IgG using its GSP/DELFIA platform; enables processing of up to 5,000 samples per day. More news on: PerkinElmer, Inc., Healthcare stocks news, Read more ...